Sanofi S.A.
Latest Sanofi S.A. News
-
Why Driving and Sleep Drugs Don't Mix
about 97 percent of the drug is out of a person's system 12.5 hours after they take it. The pill's developer, Sanofi - Aventis , says it stands behind the safety and efficacy of Ambien when used as directed, and there is a clear warning on the
-
Sleepwalking May Have Led to N.J. Woman's Drowning
medications to cases of sleepwalking and other parasomnias. In 2007, the U.S. Food and Drug Administration ordered Sanofi - Aventis to strengthen warnings on its sleep drug Ambien , after reports that the drug caused consumers to perform bizarre acts
-
Fabry Disease Patients Get Sicker as Drugs Go Overseas
contamination The company was fined $175 million and issued a consent decree to remediate. The French pharmaceutical giant Sanofi - Aventis took over the company in April. Genzyme admitted to miscalculations in its drug reserves, which caused it to cut
-
10 Top-Selling Drugs Coming Off Patent
flowing smoothly -- for about $162 per month. In 2010, Plavix earned co-marketers Bristol-Myers Squibb and Sanofi - Aventis more than $6.1 billion in U.S. sales. A generic version could be available in the U.S. in May 2012. Lipitor
-
FDA Panel Supports New Diet Pill After Rejecting Two Others
the Center for Weight Management at the Scripps Clinic in San Diego, Calif., was even more emphatic, calling the in the brain. In June 2007, its French manufacturer, Sanofi - Aventis , withdrew its FDA application. In light of obesity's
-
Dengue Fever 101
international consortium of scientists, drug manufacturers and public health institutions. The pharmaceutical company Sanofi Aventis , which has been testing its ChimeriVax dengue vaccine in tropical countries, predicts it will have a dengue vaccine
News
-
After the Headlines, What Is the Real Avandia Story?
support from AstraZeneca, Atherogenics, Eli Lilly, Novartis, Pfizer, Resverlogix, Takeda, Daiichi-Sankyo, and Sanofi - Aventis through the Cleveland Clinic Center for Clinical Research within the last five years and having consulted for a number
-
New Anti-Clotting Drug Outperforms Plavix
and six fewer cases of blocked stents. Drug maker Sanofi - Aventis , which markets Plavix in a partnership with Bristol-Myers New York City; Jan. 13, 2010, news statement, Sanofi - Aventis U.S.; Jan. 14, 2010, The Lancet , online
-
Manufacturer Recalls 800,000 Doses of H1N1 Vaccine; Flu Experts Not Worried
That's what infectious disease experts are saying about drugmaker Sanofi Pasteur's recall of about 800,000 pediatric doses weakened potency of the vaccine doses was identified by Sanofi Pasteur during routine quality assurance testing, but
-
Health Highlights: Dec. 2, 2009
disturbances; and that seizures precede cardiac dysrhythmias and death in some patients. Norpramin is made by French drugmaker Sanofi - Aventis SA. ----- Costs of Many Hospital Procedures Rise Sharply: Report Costs for 10 common hospital procedures
-
Plavix Ads Increase Medicaid Costs but not Usage
syndromes. Direct-to-consumer advertising began in 2001 by its U.S. marketers, Bristol-Myers Squibb and sanofi - aventis . The companies spent less than $10 million on consumer ads that year, but the figure quickly soared: nearly $60
-
Heartburn Drugs Can Thwart Popular Blood Thinner
the manufacturer of clopidogrel [ Sanofi - Aventis and Bristol-Myers Squibb two popular antacids. In January, Sanofi and Bristol-Myers updated Plavix's Associated Press reported. On Tuesday, Sanofi spokeswoman Noelle Boyd said the
-
Inside the H1N1 Vaccine Lab
contamination. The Sanofi Pasteur H1N1 vaccine Philadelphia. Sanofi Pasteur is one of a 500-acre Sanofi complex with over we are,' said Chris Viehbacher , CEO of parent company Sanofi - Aventis , "We are working
Videos
-
Doctor's World Health Mission
course and fifty cents. Fortune one and less than one that 400. He recently convince the giant drug manufacturer Sanofi - Aventis to produce a new anti malarial medication without a patent. Which we'll keep cost down. Zoos and didn't look
than one that -- 400. He recently convince the giant drug manufacturer Sanofi - Aventis to produce a new anti malarial medication without a patent. Which we'll keep cost down. Zoos and didn't look quote sack. Would








